Will China’s Retaliatory Tariffs Galvanize Manufacturing Onshoring?

Some Firms Are Already Localizing

 
• By Dexter Jie Yan
  
China ran a deficit of $3bn in the drug trade with the US in 2024. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia